EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The best anti-HCV S/Co values for reflecting HCV infection in a university hospital in the eastern part of Turkey

Bülent Dabanlıoğlu, Aysun Yılmaz, Sümeyye Akyüz, Barış Gülhan

The Journal of Infection in Developing Countries · 31.01.2024 · 18 (01) · 131-135

DOI: 10.3855/jidc.18105 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, online erschienen am 31.01.2024. Verfasst von Bülent Dabanlıoğlu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Erzincan Binali Yıldırım University, Faculty of Medicine, Department of Medical Microbiology, Erzincan, Turkey. Hauptthemen laut MEDLINE: Hepacivirus, Hepatitis C. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The measurement of hepatitis C virus (HCV) RNA is a test that requires high cost, advanced technique, and qualified personnel. Diagnosis and treatment of patients may be delayed due to the high rate of false-positive results. This study aims to predict true antibody positivity and viremia by determining the most appropriate anti-HCV signal-to-cutoff (S/Co) value reflecting HCV infection. Methodology: The presence of anti-HCV antibodies and HCV RNA levels were examined in 72341 people who applied to the Mengücek Gazi Training and Research Hospital between January 2018 and December 2020. The anti-HCV levels were determined by using the Abbot Architect i2000 SR device (Abbot Diagnostics, Chicago, IL, USA). The levels of HCV RNA were determined in the COBAS AmpliPrep/COBAS, TaqMan 48 (Roche, Diagnostics, Pleasanton, USA) devices using serum samples from patients. Our study is a retrospective and methodological study.

Results

Of the 150 patients with anti-HCV antibodies, 50 (33.3%) were HCV RNA positive, and 100 (66.7%) were HCV RNA negative. Anti-HCV levels of HCV RNA-positive patients were statistically higher than HCV RNA-negative patients. The most appropriate anti-HCV S/Co value for diagnosing hepatitis C patients was 15.4. The sensitivity of this value was 72%, specificity 88%, positive predictive value (PPV) 73.5%, and negative predictive value (NPV) 86.1%. Receiver operating characteristic (ROC) curve was significantly higher than 0.5 (95% confidence interval 0.938-0.827).

Conclusions

Correct approaches can be applied in the diagnosis of HCV infection using the anti-HCV S/Co value found in our study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepacivirusHepatitis CHumansHepatitis C AntibodiesRetrospective StudiesTurkeyRNA, ViralHospitalsSensitivity and Specificity

Stichwörter der Autor:innen

HCV RNAS/Coanti-HCV

Substanzen

Hepatitis C AntibodiesRNA, Viral

Autor:innen und Institutionen

  • Erzincan Binali Yıldırım University, Faculty of Medicine, Department of Medical Microbiology, Erzincan, Turkey.

Zitieren

APA

Dabanlıoğlu, B., Yılmaz, A., Akyüz, S., & Gülhan, B. (2024). The best anti-HCV S/Co values for reflecting HCV infection in a university hospital in the eastern part of Turkey. The Journal of Infection in Developing Countries, 18(01), 131-135. https://doi.org/10.3855/jidc.18105

Vancouver

Dabanlıoğlu B, Yılmaz A, Akyüz S, Gülhan B. The best anti-HCV S/Co values for reflecting HCV infection in a university hospital in the eastern part of Turkey. The Journal of Infection in Developing Countries. 2024;18(01):131-135. doi:10.3855/jidc.18105

BibTeX
@article{Dabanlolu2024,
  author = {Dabanlıoğlu, Bülent and Yılmaz, Aysun and Akyüz, Sümeyye and Gülhan, Barış},
  title = {The best anti-HCV S/Co values for reflecting HCV infection in a university hospital in the eastern part of Turkey},
  journal = {The Journal of Infection in Developing Countries},
  year = {2024},
  volume = {18},
  number = {01},
  pages = {131--135},
  doi = {10.3855/jidc.18105}
}
Kostenlos starten →